|
1
|
Guthrie RA and Guthrie DW: Pathophysiology
of diabetes mellitus. Crit Care Nurs Q. 27:113–125. 2004.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Islam MA, Amin MN, Siddiqui SA, Hossain
MP, Sultana F and Kabir MR: Trans fatty acids and lipid profile: A
serious risk factor to cardiovascular disease, cancer and diabetes.
Diabetes Metab Syndr. 13:1643–1647. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Schmidt AM: Highlighting diabetes
mellitus: The epidemic continues. Arterioscler Thromb Vasc Biol.
38:e1–e8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tung CW, Hsu YC, Shih YH, Chang PJ and Lin
CL: Glomerular mesangial cell and podocyte injuries in diabetic
nephropathy. Nephrology (Carlton). 23 (Suppl 4):S32–S37.
2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Schelling JR: Tissue transglutaminase
inhibition as treatment for diabetic glomerular scarring: It's good
to be glueless. Kidney Int. 76:363–365. 2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Skill NJ, Johnson TS, Coutts IG, Saint RE,
Fisher M, Huang L, El Nahas AM, Collighan RJ and Griffin M:
Inhibition of transglutaminase activity reduces extracellular
matrix accumulation induced by high glucose levels in proximal
tubular epithelial cells. J Biol Chem. 279:47754–47762.
2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Fleckenstein B, Qiao SW, Larsen MR, Jung
G, Roepstorff P and Sollid LM: Molecular characterization of
covalent complexes between tissue transglutaminase and gliadin
peptides. J Biol Chem. 279:17607–17616. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
El Nahas AM, Abo-Zenah H, Skill NJ, Bex S,
Wild G, Griffin M and Johnson TS: Elevated
epsilon-(gamma-glutamyl)lysine in human diabetic nephropathy
results from increased expression and cellular release of tissue
transglutaminase. Nephron Clin Pract. 97:c108–c117. 2004.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Skill NJ, Griffin M, El Nahas AM, Sanai T,
Haylor JL, Fisher M, Jamie MF, Mould NN and Johnson TS: Increases
in renal epsilon-(gamma-glutamyl)-lysine crosslinks result from
compartment-specific changes in tissue transglutaminase in early
experimental diabetic nephropathy: Pathologic implications. Lab
Invest. 81:705–716. 2001.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Loeffler I and Wolf G: Transforming growth
factor-β and the progression of renal disease. Nephrol Dial
Transplant. 29 (Suppl 1):i37–i45. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Border WA and Noble NA: Evidence that
TGF-beta should be a therapeutic target in diabetic nephropathy.
Kidney Int. 54:1390–1391. 1998.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sutariya B, Jhonsa D and Saraf MN: TGF-β:
The connecting link between nephropathy and fibrosis.
Immunopharmacol Immunotoxicol. 38:39–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lee HS: Paracrine role for TGF-β-induced
CTGF and VEGF in mesangial matrix expansion in progressive
glomerular disease. Histol Histopathol. 27:1131–1141.
2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Roestenberg P, van Nieuwenhoven FA, Wieten
L, Boer P, Diekman T, Tiller AM, Wiersinga WM, Oliver N, Usinger W,
Weitz S, et al: Connective tissue growth factor is increased in
plasma of type 1 diabetic patients with nephropathy. Diabetes Care.
27:1164–1170. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wahab NA, Yevdokimova N, Weston BS,
Roberts T, Li XJ, Brinkman H and Mason RM: Role of connective
tissue growth factor in the pathogenesis of diabetic nephropathy.
Biochem J. 359:77–87. 2001.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rosenbloom J, Ren S and Macarak E: New
frontiers in fibrotic disease therapies: The focus of the Joan and
Joel rosenbloom center for fibrotic diseases at thomas jefferson
university. Matrix Biol. 51:14–25. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lu Q, Yin XX, Wang JY, Gao YY and Pan YM:
Effects of Ginkgo biloba on prevention of development of
experimental diabetic nephropathy in rats. Acta Pharmacol Sin.
28:818–828. 2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ji L, Yin XX, Wu ZM, Wang JY, Lu Q and Gao
YY: Ginkgo biloba extract prevents glucose-induced
accumulation of ECM in rat mesangial cells. Phytother Res.
23:477–485. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Wang D, Li X, Yu X, Shi Y and Yin L:
Expression of tissue transglutaminase on renal interstitial
fibrosis rats and intervention of GBE. Zhongguo Zhong Yao Za Zhi.
34:1133–1136. 2009.PubMed/NCBI(In Chinese).
|
|
20
|
Chinese Pharmacopoeia Commission.
Pharmacopoeia of the People's Republic of China. Vol. 1. Beijing.
China Medical Science and Technology Press, 2015.
|
|
21
|
Yang M, Kan L, Wu L, Zhu Y and Wang Q:
Effect of baicalin on renal function in patients with diabetic
nephropathy and its therapeutic mechanism. Exp Ther Med.
17:2071–2076. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Afghahi H, Svensson MK, Pirouzifard M,
Eliasson B and Svensson AM: Blood pressure level and risk of major
cardiovascular events and all-cause of mortality in patients with
type 2 diabetes and renal impairment: An observational study from
the swedish national diabetes register. Diabetologia. 58:1203–1211.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rogers NM, Teubner DJ and Coates PT:
Calcific uremic arteriolopathy: Advances in pathogenesis and
treatment. Semin Dial. 20:150–157. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Eberhardt W, Engels C, Müller R and
Pfeilschifter J: Mechanisms of dexamethasone-mediated inhibition of
cAMP-induced tPA expression in rat mesangial cells. Kidney Int.
62:809–821. 2002.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Fang J, Wang Z, Wang P and Wang M:
Extraction, structure and bioactivities of the polysaccharides from
Ginkgo biloba: A review. Int J Biol Macromol. 162:1897–1905.
2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Castro NE, Kato M, Park JT and Natarajan
R: Transforming growth factor β1 (TGF-β1) enhances expression of
profibrotic genes through a novel signaling cascade and microRNAs
in renal mesangial cells. J Biol Chem. 289:29001–29013.
2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Solini A, Manca ML, Penno G, Pugliese G,
Cobb JE and Ferrannini E: Prediction of declining renal function
and albuminuria in patients with type 2 diabetes by metabolomics. J
Clin Endocrinol Metab. 101:696–704. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tian J, Popal MS and Liu Y, Gao R, Lyu S,
Chen K and Liu Y: Ginkgo biloba leaf extract attenuates
atherosclerosis in streptozotocin-induced diabetic
ApoE-/- mice by inhibiting endoplasmic reticulum stress
via restoration of autophagy through the mTOR signaling pathway.
Oxid Med Cell Longev. 2019(8134678)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Coskun O, Armutcu F, Kanter M and Kuzey
GM: Protection of endotoxin-induced oxidative renal tissue damage
of rats by vitamin E or/and EGb 761 treatment. J Appl Toxicol.
25:8–12. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
30
|
Lasaite L, Spadiene A, Savickiene N,
Skesters A and Silova A: The effect of Ginkgo biloba and
Camellia sinensis extracts on psychological state and
glycemic control in patients with type 2 diabetes mellitus. Nat
Prod Commun. 9:1345–1350. 2014.PubMed/NCBI
|
|
31
|
Cui JF, Yang W, Xie YM, Sun Y, Zhuang Y
and Wang YY: Real-world analysis of concurrent diseases and
medicine use among patients with insomnia. Zhongguo Zhong Yao Za
Zhi. 39:3519–3526. 2014.PubMed/NCBI(In Chinese).
|
|
32
|
Pohlers D, Brenmoehl J, Löffler I, Müller
CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW and Wolf G:
TGF-beta and fibrosis in different organs-molecular pathway
imprints. Biochim Biophys Acta. 1792:746–756. 2009.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Serban AI, Stanca L, Geicu OI, Munteanu MC
and Dinischiotu A: RAGE and TGF-β1 cross-talk regulate
extracellular matrix turnover and cytokine synthesis in AGEs
exposed fibroblast cells. PLoS One. 11(e0152376)2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Cui Y, Robertson J, Maharaj S, Waldhauser
L, Niu J, Wang J, Farkas L, Kolb M and Gauldie J: Oxidative stress
contributes to the induction and persistence of TGF-β1 induced
pulmonary fibrosis. Int J Biochem Cell Biol. 43:1122–1133.
2011.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yin Q and Liu H: Connective tissue growth
factor and renal fibrosis. Adv Exp Med Biol. 1165:365–380.
2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Douthwaite JA, Johnson TS, Haylor JL,
Watson P and El Nahas AM: Effects of transforming growth
factor-beta1 on renal extracellular matrix components and their
regulating proteins. J Am Soc Nephrol. 10:2109–2119.
1999.PubMed/NCBI
|
|
37
|
Akimov SS and Belkin AM: Cell-surface
transglutaminase promotes fibronectin assembly via interaction with
the gelatin-binding domain of fibronectin: A role in
TGFbeta-dependent matrix deposition. J Cell Sci. 114:2989–3000.
2001.PubMed/NCBI
|
|
38
|
Zhang H, Cai X, Yi B, Huang J, Wang J and
Sun J: Correlation of CTGF gene promoter methylation with CTGF
expression in type 2 diabetes mellitus with or without nephropathy.
Mol Med Rep. 9:2138–2144. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hou X, Tian J, Geng J, Li X, Tang X, Zhang
J and Bai X: MicroRNA-27a promotes renal tubulointerstitial
fibrosis via suppressing PPARγ pathway in diabetic nephropathy.
Oncotarget. 7:47760–47776. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Tang D, Zhang Z, Gao Y, Wei Y and Han L:
Protective effects of serum containing Ginkgo biloba extract
on glomerulosclerosis in rat mesangial cells. J Ethnopharmacol.
124:26–33. 2009.PubMed/NCBI View Article : Google Scholar
|
